5.
Comparison of IFCC number among patients
| Variables | IFCC | P |
| IFCC, intraperitoneal free cancer cells; PDL, programmed cell death ligand. | ||
| Gender | 0.611 | |
| Male | 2 | |
| Female | 3 | |
| Neoadjuvant group | 0.895 | |
| Yes | 3 | |
| No | 2 | |
| Tumor stage | 0.271 | |
| T1 | 1 | |
| ≥T2 | 2 | |
| Node lymph | 0.328 | |
| Positive | 2 | |
| Negative | 1 | |
| Vascular invasion | 0.022 | |
| Positive | 3 | |
| Negative | 1 | |
| Perineural invasion | 0.441 | |
| Positive | 2 | |
| Negative | 2 | |
| Lauren type | 0.002 | |
| Intestinal | 4 | |
| Diffused | 6 | |
| Mixed | 1 | |
| Differentiation | 0.406 | |
| High | 8 | |
| Middle | 4 | |
| Low | 3 | |
| Undifferentiation | 1 | |
| Borrmann classification | 0.666 | |
| I | 2 | |
| II | 2 | |
| III | 2 | |
| IV | 10 | |
| PDL1 expression | 1.000 | |
| Positive | 3 | |
| Negative | 3 | |
| Ki67 index (%) | 0.650 | |
| 0−25 | 7 | |
| 26−50 | 2 | |
| 51−75 | 1 | |
| 76−100 | 3 | |
| Pathology | 0.012 | |
| Positive | 6 | |
| Negative | 2 | |
| Conventional cytology | 0.022 | |
| Positive | 8 | |
| Negative | 2 | |